Brazil Makes Drug Prices Transparent To Strengthen Hand In Pricing Talks
Executive Summary
Brazil wants to drive competition and lower drug prices by obliging health authorities to publish the prices paid for all drugs bought by the national health system. A voluntary system has already helped save $1bn and cut the price of Gilead’s Sovaldi by around 30%.